DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Diel R, Hittel N, Schaberg T.
Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba™ to background regimens in Germany.
Respir Med 2015;
109: 632-641
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.